KOVINA THERAPEUTICS

kovina-therapeutics-logo

Kovina Therapeutics operates as a pre-clinical biotechnology company aims to discover a non-surgical, medical treatment for Human Papillomavirus (HPV) infections and cancers.

#SimilarOrganizations #People #Financial #Website #More

KOVINA THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2020-01-01

Address:
Indianapolis, Indiana, United States

Country:
United States

Website Url:
http://www.kovina.com

Status:
Active

Total Funding:
2 M USD

Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Webflow Webflow Hosting


Similar Organizations

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.


Current Advisors List

fritz-french_image

Fritz French Chair Of The Board Of Directors @ Kovina Therapeutics
Board_member
2020-11-01

Current Employees Featured

samy-meroueh_image

Samy Meroueh
Samy Meroueh Co-Founder @ Kovina Therapeutics
Co-Founder

zhijian-lu_image

Zhijian Lu
Zhijian Lu Co-Founder & Vice President, Medical Chemistry @ Kovina Therapeutics
Co-Founder & Vice President, Medical Chemistry

kristin-sherman_image

Kristin Sherman
Kristin Sherman Chief Executive Officer @ Kovina Therapeutics
Chief Executive Officer
2021-04-01

elliot-androphy_image

Elliot Androphy
Elliot Androphy Co-founder @ Kovina Therapeutics
Co-founder
2020-08-01

Founder


elliot-androphy_image

Elliot Androphy

samy-meroueh_image

Samy Meroueh

zhijian-lu_image

Zhijian Lu

Investors List

national-cancer-institute_image

National Cancer Institute

National Cancer Institute investment in Grant - Kovina Therapeutics

biocrossroads_image

BioCrossroads

BioCrossroads investment in Seed Round - Kovina Therapeutics

iu-ventures_image

IU Ventures

IU Ventures investment in Seed Round - Kovina Therapeutics

elevate-ventures_image

Elevate Ventures

Elevate Ventures investment in Seed Round - Kovina Therapeutics

Official Site Inspections

http://www.kovina.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Kovina Therapeutics"

Kovina Therapeutics | Antiviral Therapeutics for HPV Cancers and โ€ฆ

Kovina Therapeutics Inc. announced receipt of a Small Business Innovation Research (SBIR) one-year Phase I award from the National Institute of Allergy and Infectious โ€ฆSee details»

Kovina Therapeutics - Crunchbase Company Profile & Funding

Organization. Kovina Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Kovina Therapeutics operates as a โ€ฆSee details»

(includes ICORPS) - Elevate

Kovina Therapeutics is an early-stage drug discovery company focused on stopping HPV premalignant infections before cancer develops and treating ... Leads the organization with 30 โ€ฆSee details»

Kovina Therapeutics Company Profile 2024: Valuation, โ€ฆ

Kovina Therapeutics has raised $2.33M. Who are Kovina Therapeuticsโ€™s investors? National Institute of Dental and Craniofacial Research, National Institute Of Allergy and Infectious Diseases, National Cancer Institute, โ€ฆSee details»

Biotechnology Startup Receives Funding to Advance HPV Cancer โ€ฆ

INDIANAPOLIS (Oct. 20, 2021) โ€“ Kovina Therapeutics announced the recent close of a $2 million seed round of financing led by Elevate Ventures.Other participating investors include โ€ฆSee details»

Kovina Therapeutics - LinkedIn

Kovina Therapeutics | 265 followers on LinkedIn. Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics | Kovina Therapeutics is a ...See details»

Kovina Therapeutics - Funding, Financials, Valuation & Investors

Kovina Therapeutics operates as a pre-clinical biotechnology company. Kovina Therapeutics is funded by 6 investors. National Institute of Dental and Craniofacial Research (NIDCR) and โ€ฆSee details»

Kovina Therapeutics - VentureRadar

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral therapeutics specifically designed to treat cancers and pre-malignant infections โ€ฆSee details»

Sue Mahony, Ph.D. | Kovina Therapeutics, Inc

Dr. Mahony joined the Kovina board as a director in June 2021. From 2011 until her retirement in August 2018, she served as Senior Vice President and President of Lilly Oncology and was a member of the executive committee at โ€ฆSee details»

Kovina Therapeutics Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kovina Therapeutics Inc. of Indianapolis, IN. Get the latest business insights from Dun & Bradstreet.See details»

Kovina Therapeutics โ€“ Indiana Health Industry Forum - IHIF

Sep 28, 2023 www.kovina.com Indianapolis, IN Contact: Kristin Sherman, CEO Kovina Therapeutics is a preclinical drug discovery company focused on stopping human โ€ฆSee details»

Kovina Therapeutics Receives National Cancer Institute Grant to โ€ฆ

Jun 27, 2022 Kovina Therapeutics is a biotechnology company developing first-in-class antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV).See details»

IU-Affiliated Biotechnology Startup will use Seed Funding ... - Kovina

INDIANAPOLIS โ€” With the support of IU Ventures and the IU Innovation and Commercialization Office, Kovina Therapeutics, a preclinical biotechnology startup seeking to develop new โ€ฆSee details»

Kovina Therapeutics Receives Grant from NIH to Advance Human ...

Kovina Therapeutics Receives Grant from NIH to Advance Human ...See details»

IU-affiliated biotechnology startup will use seed funding toward ...

FOR IMMEDIATE RELEASE Nov. 15, 2021 INDIANAPOLIS โ€” With the support of IU Ventures and the IU Innovation and Commercialization Office, Kovina Therapeutics, a preclinical โ€ฆSee details»

Research programme: antiviral therapeutics - Kovina Therapeutics

01 Nov 2022 Kovina Therapeutics receives SBIR one-year phase I grant from National Institute of Dental and Craniofacial Research for antiviral therapeutics development in Oropharyngeal โ€ฆSee details»

Kovina Therapeutics Receives NIH Grant to Develop Human โ€ฆ

Nov 1, 2022 Kovina Therapeutics is a biotechnology company developing first-in-class antiviral therapies to treat cancers and premalignant infections caused by Human Papillomavirus โ€ฆSee details»

Fritz French | Kovina Therapeutics, Inc

Earlier in his career, he held numerous marketing, sales, international and general management positions for Eli Lillyโ€™s Medical Device Division and Guidant. Mr. French currently serves on the โ€ฆSee details»

Kovina Therapeutics Receives Grant from NIH to Advance Human ...

Sep 12, 2022 Kovina Therapeutics is a biotechnology company developing first-in-class antiviral therapies to treat cancers and premalignant infections caused by Human Papillomavirus (HPV).See details»

Press Releases - Kovina

Kovina is a preclinical biotechnology company developing first-in-class antiviral therapies to treat cancers and pre-cancerous malignancies associated with Human Papillomavirus (HPV). A โ€ฆSee details»

linkstock.net © 2022. All rights reserved